Key result
Review outlines the significant evolution of TAVR devices, complications, and outcomes for severe aortic stenosis.
This review summarizes the evolution, current devices, complications, and outcomes of transcatheter aortic valve replacement.
May guide TAVR updates for clinicians; leaves open prospective validation of newest devices.
Transcatheter aortic valve replacement (TAVR) initially emerged as a therapeutic option for high-risk patients with severe aortic stenosis. Advancement in technologies since the first era of TAVRs, experience from previous obstacles, and lessons learned from complications have allowed the evolution of this procedure to the current state. This review focuses on the updates on the most current devices, complications, and outcomes of TAVR.
No takes yet. Share an insight, caveat, or question.
Alfadhli et al. (2018) conducted a review in Severe aortic stenosis. Transcatheter aortic valve replacement (TAVR) was evaluated. Transcatheter aortic valve replacement (TAVR) devices, complications, and outcomes have evolved significantly, as summarized in this review of current technologies for severe aortic stenosis.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: